Category: Pharma

Executive Moves

Optibrium: James Halle

  • 16 July 2024

Optibrium, a drug discovery software provider to the pharmaceutical and biotech industries, has appointed James Halle as chief commercial officer.

Pharma
Executive Moves

Cellular Origins, a TTP company focused on enabling manufacture of cell and gene therapies, has appointed Geoffrey Hodge as a non-executive director.

Pharma
Executive Moves

CN Bio: Lydia Seymour

  • 27 June 2024

Cambridge-based CN Bio has appointed Lydia Seymour as vice-president of people and culture.

Pharma
Executive Moves

Enhanc3D Genomics, which develops disruptive technologies to unlock the 3D spatial genome for target and biomarker discovery, has appointed Hazel Jones as chief executive.

Pharma
Executive Moves

Paris-based biopharma private equity fund Jeito Capital has appointed Sarah Leroy to the newly created position of secretary general.

Pharma
Executive Moves

Nuclera, a biotechnology company enabling rapid protein expression and purification screening through its benchtop protein platform, has appointed Joseph Bertelsen as chief commercial officer.

Pharma
Executive Moves

Maxion Therapeutics, a biotechnology company developing antibody-based drugs for previously untreatable ion channel- and GPCR-driven diseases, has appointed Dr Arndt Schottelius as chief executive.

Pharma
Executive Moves

CN Bio: Joseph Parisi

  • 31 January 2024

CN Bio, an organ-on-a-chip company that designs and manufactures single-and multi-organ microphysiological systems, has appointed Joseph Parisi as US director of sales.

Pharma
Executive Moves

Enhanc3D Genomics, which develops disruptive technologies to unlock the 3D spatial genome for target and biomarker discovery, has appointed Dr Daniel Turner as chief scientific officer.

Pharma
News

Cumulus Oncology has raised £9 million in seed ¬financing in a round led by existing investor Eos Advisory and new corporate investor, the Scottish National Investment Bank.

Pharma
Executive Moves

Arecor Therapeutics has appointed Dr Helen Parris as senior vice-president, commercial, as well as general manager of the group’s subsidiary company, Tetris Pharma.

Pharma
News

London-based Celadon Pharmaceuticals, which focuses on the development, production and sale of cannabis-based medicines, is raising £2 million through a share issue.

Pharma
Executive Moves

Camena Bioscience, a synthetic biology company providing genes to the pharmaceutical and biotechnology industries, has appointed Dr Nicola Thompson as its chair

Pharma
Executive Moves

Cyted: Gail Marcus

  • 30 November 2023

Cyted, which works on non-endoscopic diagnostics for digestive diseases, has appointed Gail Marcus as its chair and a non-executive director.

Pharma
Executive Moves

Forward Partners-backed Sonrai Analytics, an AI precision medicine company, has appointed Paul Jones as chairman.

Pharma
Executive Moves

Avacta Group, a life sciences company developing oncology drugs and diagnostics, has appointed Shaun Chilton as a non-executive director.

Pharma

Partners